# Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy

> **NCT06958445** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Taipei City Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Breast Carcinoma

## Interventions

- **DRUG:** Alginos Oral Suspension

## Key facts

- **NCT ID:** NCT06958445
- **Lead sponsor:** Taipei City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-02-15
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06958445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06958445, "Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06958445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*